Objective sleep duration and response to combined pharmacotherapy and cognitive behavioral insomnia therapy among patients with comorbid depression and insomnia: a report from the TRIAD study.

ABSTRACT:

Study objectives

Several studies have shown that patients with short sleep duration show a poor response to cognitive behavioral therapy for insomnia (CBT-I), but such studies have not included patients with comorbid conditions. The current study was conducted to determine whether pretreatment sleep duration moderates the response of patients with major depression and insomnia disorders to a combined CBT-I and antidepressant medication treatment.

Methods

This study comprised a secondary analysis of a larger randomized trial that tested combined CBT-I/antidepressant medication treatment of patients with major depression and insomnia. Participants (n = 99; 70 women; M_age = 47.712.4 years) completed pretreatment polysomnography and then were randomly assigned to a 12

SUBMITTER: Edinger JD 

PROVIDER: S-EPMC10235719 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature